Kelly K. Hunt

1994–2026 年に発表

323
論文数
48,889
被引用数
129
h 指数
311
i10 指数

被引用数

Kelly K. Hunt の年別被引用数1974 年: 被引用 1 件1982 年: 被引用 1 件1989 年: 被引用 1 件1996 年: 被引用 4 件1997 年: 被引用 5 件1998 年: 被引用 9 件1999 年: 被引用 25 件2000 年: 被引用 47 件2001 年: 被引用 61 件2002 年: 被引用 94 件2003 年: 被引用 106 件2004 年: 被引用 146 件2005 年: 被引用 204 件2006 年: 被引用 240 件2007 年: 被引用 292 件2008 年: 被引用 249 件2009 年: 被引用 268 件2010 年: 被引用 319 件2011 年: 被引用 285 件2012 年: 被引用 272 件2013 年: 被引用 343 件2014 年: 被引用 358 件2015 年: 被引用 291 件2016 年: 被引用 316 件2017 年: 被引用 338 件2018 年: 被引用 283 件2019 年: 被引用 1,224 件2020 年: 被引用 1,322 件2021 年: 被引用 1,223 件2022 年: 被引用 840 件2023 年: 被引用 644 件2024 年: 被引用 1,106 件2025 年: 被引用 468 件2026 年: 被引用 22 件1975〜1981 年は被引用が無いため表示していません1983〜1988 年は被引用が無いため表示していません1990〜1995 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,927 件、この内訳の 31.4%中国: 引用元論文 1,089 件、この内訳の 8.7%イギリス: 引用元論文 755 件、この内訳の 6%イタリア: 引用元論文 679 件、この内訳の 5.4%ドイツ: 引用元論文 556 件、この内訳の 4.5%フランス: 引用元論文 462 件、この内訳の 3.7%オランダ: 引用元論文 437 件、この内訳の 3.5%カナダ: 引用元論文 415 件、この内訳の 3.3%スペイン: 引用元論文 331 件、この内訳の 2.7%日本: 引用元論文 309 件、この内訳の 2.5%スイス: 引用元論文 283 件、この内訳の 2.3%オーストラリア: 引用元論文 264 件、この内訳の 2.1%
0%31.4%その他 23.9%

分野

  • Medicine48.6%
  • Biochemistry, Genetics and Molecular Biology44.6%
  • Immunology and Microbiology1.4%
  • Engineering1.2%
  • Agricultural and Biological Sciences1.1%
  • Computer Science1%
  • その他2.1%

トピック

  • Breast Cancer Treatment Studies15.3%
  • Breast Lesions and Carcinomas8.2%
  • Breast Implant and Reconstruction6.5%
  • HER2/EGFR in Cancer Research3.3%
  • Advanced Breast Cancer Therapies2.5%
  • Sarcoma Diagnosis and Treatment2.2%
  • その他62%

共著者

全論文

検索で開く
  1. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis

    著者: , , , , , , , , , , , , , - JAMA 2017 被引用: 1,862

  2. Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 被引用: 718

  3. Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2016 被引用: 889

  4. Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Toru Watanabe, Greg Yothers, Ke‐Da Yu, Richard Berry, Clare Boddington, Mike Clarke, Christina Davies, Lucy Davies, Frances Duane, Vaughan Evans, Jo Gay, Lucy Gettins, Jon Godwin, Sam James, Hui Lui, Zulian Lui, Elizabeth MacKinnon, Gurdeep Mannu, Theresa McHugh, Philip Morris, Simon Read, Ewan Straiton, Aman U. Buzdar, Vera J. Suman, Kelly K. Hunt, Robert Leonard, Janine Mansi, Catherine Delbaldo, Pascal Piedbois, Emmanuel Quinaux, Christian Fesl, Michael Gnant, Lidija Sölkner, Guenther G. Steger, Hans Petter Eikesdal, Per Eystein Lønning, Valerie Bée, Helena Fung, John R. Mackey, Miguel Martín, Michael F. Press, Evandro de Azambuja, Richard D. Gelber, Meredith M. Regan, Angelo Di Leo, Veerle Van Dooren, J.-M. Nogaret, John M.S. Bartlett, Bingshu E. Chen, Karen A. Gelmon, Paul E. Goss, Mark N. Levine, Wendy R. Parulekar, Kathleen I. Pritchard, Lois E. Shepherd, Donald A. Berry, Constance Cirrincione, Lawrence N. Shulman, Eric P. Winer, Rebecca Gelman, Jay R. Harris, Craig Henderson, Charles L. Shapiro, Peer Christiansen, Marianne Ewertz, Henning T. Mouridsen, Elise Van Leeuwen, Sabine C. Linn, Annelot G.J. van Rossum, Harm van Tinteren ほか 136 名 - The Lancet 2023 被引用: 189

  5. Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kelly K. Hunt - Journal of Clinical Oncology 2017 被引用: 411

  6. Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: a multicentre, single-arm, phase 2 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ana P Refinetti, Monica L. Huang, Rosalind P. Candelaria, Catherine Loveland‐Jones, Melissa P. Mitchell, Simona F. Shaitelman - The Lancet Oncology 2022 被引用: 161

  7. Surgical Complications Associated With Sentinel Lymph Node Dissection (SLND) Plus Axillary Lymph Node Dissection Compared With SLND Alone in the American College of Surgeons Oncology Group Trial Z0011

    著者: , , , , , , , , , - Journal of Clinical Oncology 2007 被引用: 911

  8. CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancers

    著者: , , , , , , , , , , , , , , , , - Nature Communications 2017 被引用: 293

  9. Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases

    著者: , , , , , , , , , - Annals of Surgery 2010 被引用: 1,254

  10. Prediction of pathologic complete response to neoadjuvant systemic therapy in triple negative breast cancer using deep learning on multiparametric MRI

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Scientific Reports 2023 被引用: 43

  11. Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women With Estrogen Receptor–Rich Stage 2 to 3 Breast Cancer: Clinical and Biomarker Outcomes and Predictive Value of the Baseline PAM50-Based Intrinsic Subtype—ACOSOG Z1031

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2011 被引用: 560

  12. Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor–Positive Metastatic Breast Cancers

    著者: , , , , , , , , , , , , , , - Cancer Research 2023 被引用: 52

  13. Identification and Resection of Clipped Node Decreases the False-negative Rate of Sentinel Lymph Node Surgery in Patients Presenting With Node-positive Breast Cancer (T0–T4, N1–N2) Who Receive Neoadjuvant Chemotherapy

    著者: , , , , , , , , , - Annals of Surgery 2015 被引用: 453

  14. Combined Inhibition of STAT3 and DNA Repair in Palbociclib-Resistant ER-Positive Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2019 被引用: 133

  15. Whole-genome analysis informs breast cancer response to aromatase inhibition

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Julie A. Margenthaler, Gildy V. Babiera, P. Kelly Marcom, J. Michael Guenther, Marilyn Leitch, Kelly K. Hunt, John A. Olson, Tao Yu, Christopher A. Maher, Lucinda Fulton, Robert S. Fulton, Michelle Harrison, Ben Oberkfell, Feiyu Du, Ryan Demeter, Tammi L. Vickery, Adnan Elhammali, Helen Piwnica‐Worms, Sandra McDonald, Mark A. Watson, David J. Dooling, David M. Ota, Li-Wei Chang, Ron Bose, Timothy J. Ley, David Piwnica‐Worms, Joshua M. Stuart, Richard K. Wilson, Elaine R. Mardis - Nature 2012 被引用: 1,035

  16. Intraoperative Fluorescence Guidance for Breast Cancer Lumpectomy Surgery

    著者: , , , , , , , , , , , , , , , , , , , , , - NEJM Evidence 2023 被引用: 48

  17. Tumor Biology Correlates With Rates of Breast-Conserving Surgery and Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer

    著者: , , , , , , , , , - Annals of Surgery 2014 被引用: 432

  18. Loss of HER2 Amplification Following Trastuzumab-Based Neoadjuvant Systemic Therapy and Survival Outcomes

    著者: , , , , , , , , , , , , - Clinical Cancer Research 2009 被引用: 334

  19. Ten-Year Outcomes of Patients With Breast Cancer With Cytologically Confirmed Axillary Lymph Node Metastases and Pathologic Complete Response After Primary Systemic Chemotherapy

    著者: , , , , , , , , , , , , , , - JAMA Oncology 2015 被引用: 162

  20. Surgical Complications Associated With Sentinel Lymph Node Biopsy: Results From a Prospective International Cooperative Group Trial

    著者: , , , , , , , , , , , - Annals of Surgical Oncology 2006 被引用: 581

  21. Cyclin E Overexpression Sensitizes Triple-Negative Breast Cancer to Wee1 Kinase Inhibition

    著者: , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2018 被引用: 116

  22. A Phase II Trial Exploring the Success of Cryoablation Therapy in the Treatment of Invasive Breast Carcinoma: Results from ACOSOG (Alliance) Z1072

    著者: , , , , , , , , , , , , , , , , , , , , , - Annals of Surgical Oncology 2016 被引用: 165

  23. Clinical Course of Breast Cancer Patients With Complete Pathologic Primary Tumor and Axillary Lymph Node Response to Doxorubicin-Based Neoadjuvant Chemotherapy

    著者: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 1999 被引用: 1,337

  24. Comparison of Cancer Prevalence in Patients With Neurofibromatosis Type 1 at an Academic Cancer Center vs in the General Population From 1985 to 2020

    著者: , , , , , , , , , , , , , , , - JAMA Network Open 2021 被引用: 174